110 related articles for article (PubMed ID: 11952509)
21. [Efficacy of 2 cholesterol apheresis systems].
Schooneman F; Ziegler O; Briquel ME; Streiff F
Ann Med Interne (Paris); 1990; 141(7):600-3. PubMed ID: 2085238
[TBL] [Abstract][Full Text] [Related]
22. Treatment of homozygous patients with familial hypercholesterolemia by double-filtration plasmapheresis.
Mabuchi H; Michishita I; Sakai T; Sakai Y; Watanabe A; Wakasugi T; Takeda R
Atherosclerosis; 1986 Aug; 61(2):135-40. PubMed ID: 3463306
[TBL] [Abstract][Full Text] [Related]
23. Effect of membrane trapping in plasma fractionator on separative characteristics.
Mineshima M; Agishi T; Hasuo Y; Kaneko I; Era K; Ota K
Int J Artif Organs; 1988 May; 11(3):191-4. PubMed ID: 3403057
[TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of two types of LDL apheresis module and effect of repetitive LDL apheresis on plasma cholesterol levels and aortic atherosclerosis in heterozygous WHHL rabbits.
Kim SS; Kutsumi Y; Nakai T; Miyabo S
Jpn Circ J; 1991 Jan; 55(1):68-80. PubMed ID: 2010950
[TBL] [Abstract][Full Text] [Related]
25. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. The HELP-Study Group. Heparin-induced extra-corporeal LDL-precipitation.
Schuff-Werner P; Gohlke H; Bartmann U; Baggio G; Corti MC; Dinsenbacher A; Eisenhauer T; Grützmacher P; Keller C; Kettner U
Eur J Clin Invest; 1994 Nov; 24(11):724-32. PubMed ID: 7890009
[TBL] [Abstract][Full Text] [Related]
26. Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal.
Lane DM; McConathy WJ; Laughlin LO; Comp PC; von Albertini B; Gibson SM; Bricker LA; Kozlovskis P; Dorrier C
Am J Cardiol; 1993 Apr; 71(10):816-22. PubMed ID: 8456760
[TBL] [Abstract][Full Text] [Related]
27. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
Geiss HC; Otto C; Parhofer KG
Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
[TBL] [Abstract][Full Text] [Related]
28. Short- and long-term effects on serum lipoproteins by three different techniques of apheresis.
Richter WO; Donner MG; Schwandt P
Artif Organs; 1996 Apr; 20(4):311-7. PubMed ID: 8860712
[TBL] [Abstract][Full Text] [Related]
29. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
Gong D; Ji D; Xu B; Liu Z
Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations.
Sueoka A
Ther Apher; 2000 Jun; 4(3):211-2. PubMed ID: 10910022
[TBL] [Abstract][Full Text] [Related]
31. Development of new hollow fiber membrane macromolecular filters.
Kayashima K; Sueoka A; Smith JW; Matsubara S; Abe Y; Ueno M; Shinagawa S; Katsume C; Malchesky PS; Nosé Y
Trans Am Soc Artif Intern Organs; 1982; 28():66-70. PubMed ID: 7164320
[TBL] [Abstract][Full Text] [Related]
32. Homozygous familial hypercholesterolemia. Selective removal of low-density lipoproteins by secondary membrane filtration.
Leitman SF; Smith JW; Gregg RE
Transfusion; 1989 May; 29(4):341-6. PubMed ID: 2718235
[TBL] [Abstract][Full Text] [Related]
33. Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a).
Waldmann E; Parhofer KG
Pathology; 2019 Feb; 51(2):227-232. PubMed ID: 30611543
[TBL] [Abstract][Full Text] [Related]
34. Maximal flow rates and sieving coefficients in different plasmafilters: effects of increased membrane surfaces and effective length under standardized in vitro conditions.
Unger JK; Haltern C; Dohmen B; Rossaint R
J Clin Apher; 2002; 17(4):190-8. PubMed ID: 12494412
[TBL] [Abstract][Full Text] [Related]
35. Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
Julius U; Parhofer KG; Heibges A; Kurz S; Klingel R; Geiss HC
J Clin Apher; 2007; 22(4):215-23. PubMed ID: 17455220
[TBL] [Abstract][Full Text] [Related]
36. Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis.
Yeh JH; Chiu HC
J Neurol; 2000 Jul; 247(7):510-3. PubMed ID: 10993491
[TBL] [Abstract][Full Text] [Related]
37. Low-density lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia.
Fernández-Fuertes LF; Tapia Martín M; Nieves Plá I; Novoa Mogollón FJ; Díaz Cremades J
Ther Apher Dial; 2010 Oct; 14(5):484-5. PubMed ID: 21175548
[No Abstract] [Full Text] [Related]
38. Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia.
Goldammer A; Wiltschnig S; Heinz G; Jansen M; Stulnig T; Hörl WH; Derfler K
Metabolism; 2002 Aug; 51(8):976-80. PubMed ID: 12145769
[TBL] [Abstract][Full Text] [Related]
39. Reverse flux filtration: a new mode of therapy improving the efficacy of heparin-induced extracorporeal LDL precipitation in hyperlipidemic hemodialysis patients.
Bosch T; Samtleben W; Thiery J; Gurland HJ; Seidel D
Int J Artif Organs; 1993 Feb; 16(2):75-85. PubMed ID: 8486416
[TBL] [Abstract][Full Text] [Related]
40. Double filtration plasmapheresis in different diseases in Thailand.
Lumlertgul D; Suteeka Y; Tumpong S; Bunnachak D; Boonkaew S
Ther Apher Dial; 2013 Feb; 17(1):99-116. PubMed ID: 23379501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
